The Department of Endocrinology, 
Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs).
- Department of Endocrinology, Bharti Hospital, Karnal, India.
- Department of Endocrinology, Max Superspeciality Hospital, Patparganj, New Delhi, India.
- Department of Endocrinology, Diabetes and Metabolism, Christian Medical College, Vellore, India. nitin.kapoor@cmcvellore.ac.in.
- Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Victoria, Australia. nitin.kapoor@cmcvellore.ac.in.
Diabetes therapy : research, treatment and education of diabetes and related disorders Vol. 12 · Issue 8 · pp. 2133-2147
PMID 34268675 DOI 10.1007/s13300-021-01113-y
Cite This Article
Sanjay Kalra, Saptarshi Bhattacharya, Nitin Kapoor. Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs). Diabetes therapy : research, treatment and education of diabetes and related disorders. 2021;12(8):2133-2147. doi:10.1007/s13300-021-01113-y
Abstract
This communication provides a contemporary classification of glucagon-like peptide 1 receptor agonists (GLP1RAs) based on indication, route, and frequency of administration, which could support a person-centric approach to treatment choice. It includes all recently developed GLP1RAs as well as those in advanced stages of clinical study. Keeping pace with current trends in pharmacology and metabolic medicine, it attempts to bring clarity and simplicity to a complex spread of information.
Keywords
- Danuglipron
- Dulaglutide
- Exenatide
- Exenatide LAR
- GLP1RA
- IDegLira
- IcoSema
- Liraglutide
- LixiLan
- Person-centric care
- Semaglutide
- Tirzepatide
